You can find the annual or quarterly income statement of aTyr Pharma Ord Shs here for insights into the performance and operational efficiency of aTyr Pharma Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q4

FY2025Q3

Total revenue

--110.08M

--93.79M

Revenue

--110.08M

--93.79M

Cost of revenue

--3.34M

--3.01M

Operating expenses

--85.61M

--76.72M

R&D expenses

----

--22.13M

Depreciation, depletion, and amortization

--1.28M

--1.33M

Operating profit

--24.47M

--17.07M

Net non-operating interest income (expenses)

Non-operating interest income

--1.36M

--1.41M

Non-operating interest expense

--765.00K

--786.00K

Other non-operating income (expenses)

--61.00K

--42.00K

Income before tax

--25.13M

--17.74M

Income tax

--564.00K

--1.86M

Income after tax

--24.56M

--15.87M

Net income from continuous operations

----

--15.87M

Net Income attributable to non-controlling interests

----

---2.00K

Net income attributable to controlling interests

----

--15.87M

Net income attributable to common shareholders

----

--15.87M

Basic earnings per share

----

--0.25

Diluted earnings per share

----

--0.25

Dividend per share

----

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

